Tag Archive | "Alzheimer’s Disease"

PPMI Participating in Upcoming Datathon

The tranSMART Foundation is hosting the Cross Neurodegenerative Diseases Datathon June 30 - July 2. Scientists will use the tranSMART Platform to perform analyses across multiple public datasets in the neurodegenerative disease field, including PPMI, BioFIND, LRRK2, ADNI, and GEO PD.

Continue reading...

PPMI at AD/PD 2015

PPMI is proud to be well-represented at the 12th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD 2015), which is being held March 18-22 in Nice, France. Find out when PPMI data will be presented.

Continue reading...

Funding for Biomarkers Across Neurodegenerative Diseases

For the second year, PPMI is participating in the Biomarkers Across Neurodegenerative Diseases (BAND) program. The Alzheimer's Association, Alzheimer's Research UK, The Michael J. Fox Foundation and the Weston Brain Institute announce a collaborative Request for Applications to stimulate analyses across Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases.

Continue reading...

Funding Opportunity for Research in PPMI and ADNI

A new funding opportunity for research into both Parkinson's and Alzheimer's has been launched. The Michael J. Fox Foundation, the Alzheimer?s Association and The W. Garfield Weston Foundation have launched a new grant program to inspire scientists to envision research projects that will use existing data and/or biological samples from PPMI and another large-scale biomarker study, the Alzheimer?s Disease Neuroimaging Initiative (ADNI).

Continue reading...

PPMI Profiled in ‘Practical Neurology’

A summary of the Parkinson's Progression Markers Initiative (PPMI) was recently published in Practical Neurology. The article gives a detailed account of the history and rationale of the study, as well as an overview of the study protocol. The newly added Prodromal and Genetic cohorts are also described in detail, as well as the potential overlap with the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Continue reading...

PPMI PI Ken Marek interviewed on Medscape

Ken Marek, PPMI PI and Senior Scientist at the Institute for Neurodegenerative Disorders, was interviewed in an online video on Medscape.com. Dr. Marek discussed the goals of PPMI and the current state of biomarker research in PD in general. He also discussed the recent publication on the first results from PPMI, and the overlap among neurodegenerative diseases in terms of pathology.

Continue reading...

PPMI featured in article on commonalities in PD and AD

Pharmaceutical Approvals Monthly profiled PPMI in an article last month, highlighting the similarities across neurodegenerative diseases like Parkinson's Disease and Alzheimer's Disease. PPMI PI Ken Marek was interviewed for the piece, and the article also focuses on the newly added Prodromal and Genetic Cohorts.

Continue reading...

PPMI PI Ken Marek at the Alzheimer’s Association 2013 International Conference

Last month, PPMI PI Ken Marek presented on PPMI at the Alzheimer's Association International Conference pre-conference Imaging Consortium and the coinciding World Wide Alzheimer's Disease Neuroimaging Initiative (WW-ADNI) in Boston, Massachusetts

Continue reading...